Romney M. Humphries

12.7k total citations · 1 hit paper
232 papers, 6.8k citations indexed

About

Romney M. Humphries is a scholar working on Clinical Biochemistry, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Romney M. Humphries has authored 232 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Clinical Biochemistry, 92 papers in Molecular Medicine and 88 papers in Infectious Diseases. Recurrent topics in Romney M. Humphries's work include Bacterial Identification and Susceptibility Testing (95 papers), Antibiotic Resistance in Bacteria (92 papers) and Antibiotics Pharmacokinetics and Efficacy (52 papers). Romney M. Humphries is often cited by papers focused on Bacterial Identification and Susceptibility Testing (95 papers), Antibiotic Resistance in Bacteria (92 papers) and Antibiotics Pharmacokinetics and Efficacy (52 papers). Romney M. Humphries collaborates with scholars based in United States, Canada and Spain. Romney M. Humphries's co-authors include Janet A. Hindler, Peera Hemarajata, Shelley A. Miller, Theodoros Kelesidis, Daniel Z. Uslan, George Sakoulas, Ritu Banerjee, Andrea J. Linscott, Simon Pollett and Shangxin Yang and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Romney M. Humphries

216 papers receiving 6.7k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests

2018 519 citations Romney M. Humphries, Janet A. Hindler et al. Journal of Clinical Microbiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Romney M. Humphries United States	48	2.8k	2.1k	2.0k	1.5k	1.3k	232	6.8k
Vincent Cattoir France	45	3.3k 1.2×	2.0k 0.9×	1.3k 0.7×	1.6k 1.1×	901 0.7×	228	7.5k
M.Á. Domínguez Spain	41	2.6k 0.9×	1.6k 0.8×	1.1k 0.6×	1.6k 1.0×	835 0.6×	154	5.3k
Alexander J. Kallen United States	36	2.5k 0.9×	1.9k 0.9×	1.2k 0.6×	1.8k 1.2×	881 0.7×	101	6.3k
Stephen G. Jenkins United States	45	3.1k 1.1×	1.7k 0.8×	1.9k 0.9×	2.3k 1.5×	1.3k 0.9×	152	6.3k
Cheol‐In Kang South Korea	43	3.2k 1.1×	2.3k 1.1×	1.7k 0.9×	3.2k 2.2×	1.1k 0.8×	283	8.1k
Jan Kluytmans Netherlands	42	2.4k 0.9×	3.1k 1.5×	1.5k 0.8×	2.1k 1.4×	600 0.4×	199	8.5k
Douglas J. Biedenbach United States	44	2.9k 1.0×	2.2k 1.0×	1.8k 0.9×	2.0k 1.3×	1.9k 1.4×	153	6.1k
Alasdair MacGowan United Kingdom	47	2.8k 1.0×	2.2k 1.1×	1.6k 0.8×	2.3k 1.5×	2.8k 2.1×	284	8.4k
Arnfinn Sundsfjord Norway	49	4.1k 1.5×	2.3k 1.1×	1.5k 0.7×	1.4k 0.9×	730 0.5×	156	8.4k
Thomas R. Fritsche United States	54	2.3k 0.8×	3.6k 1.7×	1.7k 0.9×	2.1k 1.4×	1.7k 1.2×	198	8.2k

Countries citing papers authored by Romney M. Humphries

Since Specialization

Citations

This map shows the geographic impact of Romney M. Humphries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Romney M. Humphries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Romney M. Humphries more than expected).

Fields of papers citing papers by Romney M. Humphries

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Romney M. Humphries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Romney M. Humphries. The network helps show where Romney M. Humphries may publish in the future.

Co-authorship network of co-authors of Romney M. Humphries

This figure shows the co-authorship network connecting the top 25 collaborators of Romney M. Humphries. A scholar is included among the top collaborators of Romney M. Humphries based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Romney M. Humphries. Romney M. Humphries is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jorth, Peter, Theodore L. McLemore, Romney M. Humphries, et al.. (2025). Evaluation of antimicrobial susceptibility testing methods for Burkholderia cepacia complex isolates from people with and without cystic fibrosis. Journal of Clinical Microbiology. 63(2). e0148024–e0148024. 1 indexed citations

Joshi, Bhavin, et al.. (2025). Exploring Family Experiences With Section 504 Plans for Their Autistic Children. Journal of Autism and Developmental Disorders.

Jacobs, Emily, Amira A. Bhalodi, Sukantha Chandrasekaran, et al.. (2025). Defining antimicrobial susceptibility testing methods and breakpoints among Achromobacter species. Journal of Clinical Microbiology. 63(6). e0026425–e0026425. 2 indexed citations

Bonomo, Robert A., Romney M. Humphries, Fredrick M. Abrahamian, et al.. (2024). 2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Complicated Intra-abdominal Infections: Utility of Intra-abdominal Fluid Cultures in Adults, Children, and Pregnant People. Clinical Infectious Diseases. 79(Supplement_3). S123–S126. 7 indexed citations

Hayden, Mary K., Kimberly E. Hanson, Janet A. Englund, et al.. (2024). Infectious Diseases Society of America Guidelines on the Diagnosis of Coronavirus Disease 2019: Serologic Testing. Clinical Infectious Diseases. 13 indexed citations

Humphries, Romney M., et al.. (2024). Multicenter evaluation of BioCode GPP for syndromic molecular detection of gastrointestinal pathogens from stool specimens. Journal of Clinical Microbiology. 62(3). e0154523–e0154523. 4 indexed citations

Freiberg, Jeffrey A., Lili Tao, Laura A. Mike, et al.. (2024). A multi-species outbreak of VIM-producing carbapenem-resistant bacteria in a burn unit and subsequent investigation of rapid development of cefiderocol resistance. Antimicrobial Agents and Chemotherapy. 68(4). e0150723–e0150723. 5 indexed citations

Tekle, Tsigereda, Yehudit Bergman, Jennifer Lu, et al.. (2023). Clinical significance of Nosocomiicoccus ampullae isolated from blood cultures. Microbiology Spectrum. 11(6). e0217923–e0217923.

Tao, Lili, Romney M. Humphries, Ritu Banerjee, & David C. Gaston. (2023). Re-emergence ofParechovirus: 2017–2022 National Trends of Detection in Cerebrospinal Fluid. Open Forum Infectious Diseases. 10(3). ofad112–ofad112. 4 indexed citations

10.

Humphries, Romney M.. (2022). Ad Hoc Antimicrobial Susceptibility Testing from MALDI-TOF MS Spectra in the Clinical Microbiology Laboratory. Clinical Chemistry. 68(9). 1118–1120. 4 indexed citations

11.

Greninger, Alexander L., Jennifer Dien Bard, Robert C. Colgrove, et al.. (2021). Clinical and Infection Prevention Applications of Severe Acute Respiratory Syndrome Coronavirus 2 Genotyping: an Infectious Diseases Society of America/American Society for Microbiology Consensus Review Document. Journal of Clinical Microbiology. 60(1). e0165921–e0165921. 6 indexed citations

12.

Bhalodi, Amira A., et al.. (2021). Variability of Beta-Lactam Broth Microdilution for Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 65(10). e0064021–e0064021. 6 indexed citations

13.

Khan, Ayesha, et al.. (2021). Evaluation of the Performance of Manual Antimicrobial Susceptibility Testing Methods and Disk Breakpoints for Stenotrophomonas maltophilia. Antimicrobial Agents and Chemotherapy. 65(5). 24 indexed citations

14.

Skov, Robert, Erika Matuschek, Jenny Åhman, et al.. (2019). EUCAST disc diffusion criteria for the detection of mecA-Mediated β-lactam resistance in Staphylococcus pseudintermedius: oxacillin versus cefoxitin. Clinical Microbiology and Infection. 26(1). 122.e1–122.e6. 11 indexed citations

15.

Humphries, Romney M., et al.. (2018). The Continued Value of Disk Diffusion for Assessing Antimicrobial Susceptibility in Clinical Laboratories: Report from the Clinical and Laboratory Standards Institute Methods Development and Standardization Working Group. Journal of Clinical Microbiology. 56(8). 59 indexed citations

16.

Chew, Kara W, et al.. (2017). Implementation of a Large System-Wide Hepatitis C Virus Screening and Linkage to Care Program for Baby Boomers. Open Forum Infectious Diseases. 4(3). ofx109–ofx109. 36 indexed citations

17.

Allan‐Blitz, Lao‐Tzu, et al.. (2017). Epidemiology ofNeisseria gonorrhoeaeGyrase A Genotype, Los Angeles, California, USA. Emerging infectious diseases. 23(9). 1581–1584. 4 indexed citations

18.

Humphries, Romney M., Max T. Wu, Lars F. Westblade, et al.. (2016). In Vitro Antimicrobial Susceptibility of Staphylococcus pseudintermedius Isolates of Human and Animal Origin. Journal of Clinical Microbiology. 54(5). 1391–1394. 12 indexed citations

19.

Yi, Jumi, et al.. (2015). Bergeyella zoohelcum Associated with Abscess and Cellulitis After a Dog Bite. The Pediatric Infectious Disease Journal. 35(2). 214–216. 8 indexed citations

20.

Humphries, Romney M., Daniel Z. Uslan, & Zachary Rubin. (2012). Performance of Clostridium difficile Toxin Enzyme Immunoassay and Nucleic Acid Amplification Tests Stratified by Patient Disease Severity. Journal of Clinical Microbiology. 51(3). 869–873. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact